Medifron DBT Co. Ltd (065650) — Cash Flow Reinvestment Rate
Medifron DBT Co. Ltd (065650) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting ₩522.85 Million (capex ₩22.85 Million plus investments ₩-500.00 Million) from operating cash flow of ₩6.72 Billion. See 065650 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medifron DBT Co. Ltd Cash Flow Reinvestment Rate (2011–2014)
Historical reinvestment intensity for Medifron DBT Co. Ltd across 2 annual periods. For the full cash flow conversion analysis, see 065650 operating cash flow.
Annual Cash Flow Reinvestment Rate for Medifron DBT Co. Ltd (2011–2014)
Year-by-year capital reinvestment analysis for Medifron DBT Co. Ltd. See financial flexibility index of Medifron DBT Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 1462.92x | ₩1.03 Billion | ₩701.96K | ₩26.91 Million | ▲ +94109.2% |
| 2011 | 1.55x | ₩1.42 Billion | ₩912.56 Million | ₩27.00 Million | — |